PKC iota Antikörper (AA 397-558)
-
- Target Alle PKC iota (PRKCI) Antikörper anzeigen
- PKC iota (PRKCI) (Protein Kinase C, iota (PRKCI))
-
Bindungsspezifität
- AA 397-558
-
Reaktivität
- Human, Maus, Ratte, Hund, Huhn
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser PKC iota Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunofluorescence (IF)
- Kreuzreaktivität
- Ratte (Rattus), Hund, Maus, Huhn
- Produktmerkmale
-
1. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
2. Please refer to us for technical protocols.
3. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
4. Source of all serum proteins is from USDA inspected abattoirs located in the United States. - Aufreinigung
- The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.
- Immunogen
- Human PKClambda aa. 397-558
- Klon
- 41-PKClambda
- Isotyp
- IgG1
- Top Product
- Discover our top product PRKCI Primärantikörper
-
-
- Kommentare
-
Related Products: ABIN967389, ABIN968545
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 250 μg/mL
- Buffer
- Aqueous buffered solution containing BSA, glycerol, and ≤0.09 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store undiluted at -20° C.
-
-
CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells." in: Oncogene, Vol. 20, Issue 31, pp. 4258-69, (2001) (PubMed).
: "The expression and stage-specific localization of protein kinase C isotypes during mouse preimplantation development." in: Developmental biology, Vol. 223, Issue 2, pp. 411-21, (2000) (PubMed).
: "Protein kinase C delta associates with and phosphorylates Stat3 in an interleukin-6-dependent manner." in: The Journal of biological chemistry, Vol. 274, Issue 34, pp. 24392-400, (1999) (PubMed).
: "Conventional PKC-alpha, novel PKC-epsilon and PKC-theta, but not atypical PKC-lambda are MARCKS kinases in intact NIH 3T3 fibroblasts." in: The Journal of biological chemistry, Vol. 272, Issue 7, pp. 4072-8, (1997) (PubMed).
: "A new member of the third class in the protein kinase C family, PKC lambda, expressed dominantly in an undifferentiated mouse embryonal carcinoma cell line and also in many tissues and cells." in: The Journal of biological chemistry, Vol. 269, Issue 17, pp. 12677-83, (1994) (PubMed).
: "
-
CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells." in: Oncogene, Vol. 20, Issue 31, pp. 4258-69, (2001) (PubMed).
-
- Target
- PKC iota (PRKCI) (Protein Kinase C, iota (PRKCI))
- Andere Bezeichnung
- Protein Kinase C lambda (PRKCI Produkte)
- Synonyme
- DXS1179E antikoerper, PKCI antikoerper, nPKC-iota antikoerper, aPKC[l] antikoerper, hal antikoerper, has antikoerper, PRKCI antikoerper, PKC antikoerper, 2310021H13Rik antikoerper, AI427505 antikoerper, PKClambda antikoerper, Pkci antikoerper, Pkcl antikoerper, Prkcl antikoerper, aPKClambda antikoerper, mKIAA4165 antikoerper, protein kinase C iota antikoerper, protein kinase C, iota antikoerper, PRKCI antikoerper, prkci antikoerper, Prkci antikoerper
- Hintergrund
- The Protein Kinase C (PKC) family of homologous serine/threonine protein kinases is involved in a number of processes such as growth, differentiation, and cytokine secretion. At least eleven isozymes have been described. These proteins are products of multiple genes and alternative splicing. PKC consists of a single polypeptide chain containing four conserved regions (C) and five variable regions (V). The N-terminal half containing C1, C2, V1, and V2 constitutes the regulatory domain and interacts with the PKC activators Ca2+, phospholipid, diacylglycerol, or phorbol ester. However, the novel PKC (nPKC) subfamily members ( delta, epsilon, eta, and theta isoforms) and the atypical PKC (aPKC) subfamily members (zeta, ί, and lambda isoforms) are Ca2+ independent and lack the C2 domain. The aPKC members are unique in that their activity is independent of diacylglycerols and phorbol esters. They also lack one repeat of the cysteine-rich sequences that are conserved in cPKC and nPKC. The C-terminal region of PKC contains the catalytic domain. The PKC pathway represents a major signal transduction system that is activated following ligand-stimulation of transmembrane receptors by hormones, neurotransmitters, and growth factors. PKClambda shows the highest degree of amino acid homology with PKCzeta (72%) and PKClambda mRNA is expressed in a variety of cells and tissues. The PKClambda protein kinase is capable of autophosphorylation and can be activated by phosphatidylserine, but not by other PKC activators such as diacylglycerols, Ca2+, or phorbol esters.
- Molekulargewicht
- 74 kDa
- Pathways
- Neurotrophin Signalübertragung, Cell-Cell Junction Organization, Tube Formation
-